Life Sciences
As of 1 January 2026, new price regulations issued by the Ministry of Health of the Czech Republic will come into force, governing the prices of medicinal products, medical devices, and healthcare services. In addition to partial content-related changes, they also introduce a major systemic novelty
Non-Alcoholic Beverage Does Not Mean ZERO ALCOHOL: Not All Non-Alcoholic Beverages Are Alcohol-Free
The Czech Agricultural and Food Inspection Authority (SZPI) has issued a statment regarding the labelling of non-alcoholic beverages with terms like “ZERO ALCOHOL,” “ALCOHOL-FREE,” or “0% ALCOHOL.” When can these labels be used, and is it possible to use such labels for all non-alcoholic beverages?
Compliance with the SmPC and the Presentation of Non-Registration Studies in Advertising
Informing healthcare professionals about the latest findings from studies related to medicinal products is crucial for ensuring effective and safe patient care. Access to the most recent scientific knowledge allows physicians to better understand the effects and potential side effects of medications
Advertising Medicinal Products and Medical Devices: Will the Amendment Bring Clarity or Confusion?
The Chamber of Deputies is currently discussing a long-prepared amendment to the Act on Regulation of Advertising (Chamber of Deputies Document 918, available here). The proposed amendment introduces several significant changes to the rules for advertising of medicinal products and medical devices.
Dual quality of food in the Czech Republic and Slovakia: Current facts and trends
In recent years, the issue of dual quality of food has been a frequently discussed topic, capturing the attention of not only consumers and the media but also European institutions. While the Czech Agriculture and Food Inspection Authority (SZPI) has released current information on this issue based
Advertising of medicinal products: What does the new version of SÚKL’s guidelines bring?
After more than a decade, the State Institute for Drug Control (SÚKL) has released an updated version of its guidelines UST-27 (full text available here: UST-27 version 4 - SÚKL). This new version, effective from 1 January 2025, clarifies the rules for advertising medicinal products, particularly sp
Is a patient program really a medicine advertisement? And why couldn’t a pharmaceutical company organise it?
A draft amendment to the Advertising Regulation Act has recently been published and is now due to be discussed by the Government and Parliament. It proposes a number of changes, including in the area of advertising of medicinal products. The attentive reader will be in for many surprises when readin
Will it be possible to promote hospital medical devices to the general public?
Many stakeholders in the medical device market are unaware that the current Advertising Regulation Act prohibits the promotion of medical devices intended solely for use by healthcare professionals (commonly referred to as “hospital” medical devices) to the general public.
Boundaries of telemedicine defined – what will the new decree bring?
In early October, an amendment to the Health Services Act came into force, which brought a completely new definition of telemedicine – i.e. the provision of health services via information technology. The Ministry of Health has submitted a long-awaited decree to lay down more precise rules for the p
What is the future of medical devices reimbursement regulation?
In July, the General Health Insurance Company of the Czech Republic (VZP), the major Czech payor, published updated guidelines for enlisting hospital medical devices in VZP’s product list. In this respect, Jiří Štěrba, Director of the Medical Devices Department of VZP, told Zdravotnický deník that V
Authors



















